Clinical Trials Browser

Breast Neoplasms

Neoplasm Metastasis, Skin Neoplasms, Carcinoma, Merkel Cell

Brain Neoplasms, Melanoma

Brain Neoplasms, Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Lymphatic Metastasis, Prostatic Neoplasms

Uterine Cervical Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Carcinoma, Merkel Cell

PSA Level Greater Than 0.03

Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasms, Unknown Primary, Sarcoma, Spinal Cord Compression, Thyroid Neoplasms

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Neoplasm Metastasis

Urinary Bladder Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasm Metastasis

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Bone Neoplasms

Squamous Cell Carcinoma of Head and Neck

Glioblastoma

Carcinoma, Renal Cell

Stomach Neoplasms

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Prostate Adenocarcinoma

Prostatic Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Node; Prostate

Brain Neoplasms, Melanoma

Brain Neoplasms

Clinical Trials

Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Stereotactic Radiosurgery in Treating Patients With Greater Than 3 Melanoma Brain Metastases

Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

REVELUTION

CHESS

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

SOAR

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell Carcinoma

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

RAD-VACCINE

Cement Augmentation in Preventing Vertebral Body Compression Fracture Following Spine Stereotactic Radiosurgery in Patients With Solid Tumors and Spinal Metastases

A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors

SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

OMET

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

CYTOSHRINK

Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

SACTION01

LUNAR

Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

SBRT/IL-2

CMP-001 and Pre-operative Stereotactic Body Radiation Therapy (SBRT) in Early Stage Triple Negative Breast Cancer (TNBC)

Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC

358

POSTILV

Neo-CheckRay

Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC

POSTCARD

BEPCOME-MB

Pembrolizumab In Central Nervous System Metastases